The Switzerland-based contract research organisation Celonic AG has recruited Soenke Brunswieck to its management team to oversee the company’s services to the cell and gene therapy industry. Dr Brunswieck was previously director of business development and project management at PharmaCell BV (now Lonza Netherlands BV).
Before that, he directed marketing and sales at CellGenix GmbH. Dr Brunswieck studied biology at the Technical University Munich and the Max Planck Institute of Psychiatry and obtained his PhD at the Klinikum Rechts der Isar in Munich.
Celonic announced the appointment on 8 May 2018.
Copyright 2018 Evernow Publishing Ltd.